Global Aspirin Market Insights, Forecast to 2025

Table of Contents

1 Study Coverage

• 1.1 Aspirin Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Aspirin Market Size Growth Rate by Product
  • 1.4.2 99.5% Purity
  • 1.4.3 99% Purity
  • 1.4.4 Others
• 1.5 Market by End User
  • 1.5.1 Global Aspirin Market Size Growth Rate by End User
  • 1.5.2 Tablets Product
  • 1.5.3 Capsule Product
  • 1.5.4 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Aspirin Market Size
  • 2.1.1 Global Aspirin Revenue 2014-2025
  • 2.1.2 Global Aspirin Sales 2014-2025
• 2.2 Aspirin Growth Rate by Regions
  • 2.2.1 Global Aspirin Sales by Regions
  • 2.2.2 Global Aspirin Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Aspirin Sales by Manufacturers
  • 3.1.1 Aspirin Sales by Manufacturers
  • 3.1.2 Aspirin Sales Market Share by Manufacturers
  • 3.1.3 Global Aspirin Market Concentration Ratio (CR5 and HHI)
• 3.2 Aspirin Revenue by Manufacturers
  • 3.2.1 Aspirin Revenue by Manufacturers (2014-2019)
  • 3.2.2 Aspirin Revenue Share by Manufacturers (2014-2019)
• 3.3 Aspirin Price by Manufacturers
• 3.4 Aspirin Manufacturing Base Distribution, Product Types
  • 3.4.1 Aspirin Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Aspirin Product Type
  • 3.4.3 Date of International Manufacturers Enter into Aspirin Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Aspirin Sales by Product
• 4.2 Global Aspirin Revenue by Product
• 4.3 Aspirin Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Aspirin Breakdown Data by End User

6 North America

• 6.1 North America Aspirin by Countries
  • 6.1.1 North America Aspirin Sales by Countries
  • 6.1.2 North America Aspirin Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Aspirin by Product
• 6.3 North America Aspirin by End User

7 Europe

• 7.1 Europe Aspirin by Countries
  • 7.1.1 Europe Aspirin Sales by Countries
  • 7.1.2 Europe Aspirin Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Aspirin by Product
• 7.3 Europe Aspirin by End User

8 Asia Pacific

• 8.1 Asia Pacific Aspirin by Countries
  • 8.1.1 Asia Pacific Aspirin Sales by Countries
  • 8.1.2 Asia Pacific Aspirin Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Aspirin by Product
• 8.3 Asia Pacific Aspirin by End User

9 Central & South America

• 9.1 Central & South America Aspirin by Countries
  • 9.1.1 Central & South America Aspirin Sales by Countries
  • 9.1.2 Central & South America Aspirin Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Aspirin by Product
• 9.3 Central & South America Aspirin by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Aspirin by Countries
  • 10.1.1 Middle East and Africa Aspirin Sales by Countries
  • 10.1.2 Middle East and Africa Aspirin Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Aspirin by Product
• 10.3 Middle East and Africa Aspirin by End User

11 Company Profiles

• 11.1 Bayer
  • 11.1.1 Bayer Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Bayer Aspirin Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Bayer Aspirin Products Offered
  • 11.1.5 Bayer Recent Development
• 11.2 Novacap
  • 11.2.1 Novacap Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Novacap Aspirin Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Novacap Aspirin Products Offered
  • 11.2.5 Novacap Recent Development
• 11.3 Shiono Chemical Co
  • 11.3.1 Shiono Chemical Co Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Shiono Chemical Co Aspirin Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Shiono Chemical Co Aspirin Products Offered
  • 11.3.5 Shiono Chemical Co Recent Development
• 11.4 Chemische Fabrik Weyl Gmbh
  • 11.4.1 Chemische Fabrik Weyl Gmbh Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Chemische Fabrik Weyl Gmbh Aspirin Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Chemische Fabrik Weyl Gmbh Aspirin Products Offered
  • 11.4.5 Chemische Fabrik Weyl Gmbh Recent Development
• 11.5 Eli Lilly And Co
  • 11.5.1 Eli Lilly And Co Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Eli Lilly And Co Aspirin Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Eli Lilly And Co Aspirin Products Offered
  • 11.5.5 Eli Lilly And Co Recent Development
• 11.6 Hebei Jingye Chemical Co Ltd
  • 11.6.1 Hebei Jingye Chemical Co Ltd Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Hebei Jingye Chemical Co Ltd Aspirin Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Hebei Jingye Chemical Co Ltd Aspirin Products Offered
  • 11.6.5 Hebei Jingye Chemical Co Ltd Recent Development
• 11.7 Industria Quimica Andina Y Cia Sa
  • 11.7.1 Industria Quimica Andina Y Cia Sa Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Industria Quimica Andina Y Cia Sa Aspirin Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Industria Quimica Andina Y Cia Sa Aspirin Products Offered
  • 11.7.5 Industria Quimica Andina Y Cia Sa Recent Development
• 11.8 Jqc Huayin Pharmaceutical Co Ltd
  • 11.8.1 Jqc Huayin Pharmaceutical Co Ltd Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Jqc Huayin Pharmaceutical Co Ltd Aspirin Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Jqc Huayin Pharmaceutical Co Ltd Aspirin Products Offered
  • 11.8.5 Jqc Huayin Pharmaceutical Co Ltd Recent Development
• 11.9 Lohmann Lts
  • 11.9.1 Lohmann Lts Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Lohmann Lts Aspirin Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Lohmann Lts Aspirin Products Offered
  • 11.9.5 Lohmann Lts Recent Development
• 11.10 Novacyl Sas
  • 11.10.1 Novacyl Sas Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Novacyl Sas Aspirin Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Novacyl Sas Aspirin Products Offered
  • 11.10.5 Novacyl Sas Recent Development
• 11.11 Upjohn Co
• 11.12 Shandong Xinhua Pharmaceutical Co Ltd
• 11.13 The Andhra Sugars Ltd
• 11.14 Dow Chemical Co
• 11.15 Alfred Benzon As
• 11.16 Rhodia Inc
• 11.17 Ilkim As
• 11.18 Eurand America Inc
• 11.19 Rhone Poulenc Institute De Biopharmacie
• 11.20 Noristan Ltd
• 11.21 Synthelabo Pharmacie
• 11.22 Industries Monfel S.A. De C.V.
• 11.23 Nanjing Pharmaceutical Factory
• 11.24 Jilin Pharmaceutical
• 11.25 Zhongnan Pharmaceutical
• 11.26 Jiuming Pharmaceutical
• 11.27 Hubei Ocean Biotech Co

12 Future Forecast

• 12.1 Aspirin Market Forecast by Regions
  • 12.1.1 Global Aspirin Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Aspirin Revenue Forecast by Regions 2019-2025
• 12.2 Aspirin Market Forecast by Product
  • 12.2.1 Global Aspirin Sales Forecast by Product 2019-2025
  • 12.2.2 Global Aspirin Revenue Forecast by Product 2019-2025
• 12.3 Aspirin Market Forecast by End User
• 12.4 North America Aspirin Forecast
• 12.5 Europe Aspirin Forecast
• 12.6 Asia Pacific Aspirin Forecast
• 12.7 Central & South America Aspirin Forecast
• 12.8 Middle East and Africa Aspirin Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Aspirin Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details